Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain
- 1 February 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 18 (2) , 109-114
- https://doi.org/10.1016/0304-3959(84)90878-9
Abstract
Children (3) with terminal malignancy received a continuous s.c. infusion of morphine sulfate for the control of severe pain, the morphine dose being adjusted until the patient and/or parent reported complete freedom from pain. Analgesic plasma morphine concentrations at the steady state in these patients ranged from 12.9-57 ng/ml (median 19.6 ng/ml) while receiving morphine doses of 0.45-2.0 mg/h (0.034-0.06 mg/kg per h). One patient, who received morphine 2 mg/h for 12 days demonstrated a 2-fold variation in steady-state plasma concentration during this period.This publication has 12 references indexed in Scilit:
- Continuous Subcutaneous Infusion of Morphine for the Pain of Terminal MalignancyAnnals of Internal Medicine, 1983
- Patient-controlled Analgesic Therapy, Part IVClinical Pharmacokinetics, 1982
- Morphine kinetics in cancer patientsClinical Pharmacology & Therapeutics, 1981
- Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancyThe Journal of Pediatrics, 1980
- Morphine kinetics in childrenClinical Pharmacology & Therapeutics, 1979
- Morphine IV Infusion for Chronic PainDrug Intelligence & Clinical Pharmacy, 1978
- Kinetics of intravenous and intramuscular morphineClinical Pharmacology & Therapeutics, 1978
- Kinetics of high‐dose intravenous morphine in cardiac surgery patientsClinical Pharmacology & Therapeutics, 1976
- The disposition of morphine in surgical patientsClinical Pharmacology & Therapeutics, 1975
- Morphine metabolism in manClinical Pharmacology & Therapeutics, 1974